Comparing ambulatory to inpatient percutaneous nephrolithotomy: systematic review and meta‐analysis
BJU International · 2025
DOI: 10.1111/bju.16601 ↗At a glance
Systematische Übersicht in BJU International, 2025. Written by Katie Du and 5 co-authors. Institution: Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada. Major MEDLINE topics: Nephrolithotomy, Percutaneous, Ambulatory Surgical Procedures, Kidney Calculi, Inpatients. Cited 4 times so far (Crossref); 34 references.
Abstract (original language)
Objectives
To investigate the differences in perioperative characteristics and postoperative outcomes between inpatient and ambulatory percutaneous nephrolithotomy (PCNL) with a subgroup analysis of same‐day discharge (SDD) patients, summarise published ambulatory pathways and compare cost and satisfaction data. Patients and Methods This study was completed according to the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses guidelines and registered a priori with the International Prospective Register of Systematic Reviews (PROSPERO: CRD42023438692). Ambulatory PCNL was defined as patients who were discharged after an overnight stay (≤23 h) and SDD was considered a subgroup discharged on postoperative Day 0.
Results
A total of 25 studies were included in the systematic review, of which 12 comparative studies were utilised for meta‐analysis. We had a pooled population of 2463 patients, of which 1956 (79%) ambulatory (747 [30%] SDD) and 507 (21%) inpatients. The ambulatory PCNL cohort had fewer overall complications (risk ratio [RR] 0.65, 95% confidence interval [CI] 0.47–0.90; P = 0.010); however, there were no differences in major complications (i.e., Clavien–Dindo Grade ≥III; RR 0.46; 95% CI 0.17–1.21; P = 0.12), emergency department visits (RR 1.09, 95% CI 0.69–1.74; P = 0.71), 30‐day readmission (RR 1.09, 95% CI 0.54–2.21; P = 0.81) or readmission at any point (RR 1.00, 95% CI 0.53–1.88; P = 0.99). The ambulatory PCNL cohort was more likely to be stone‐free defined by imaging (RR 1.35, 95% CI 1.09–1.66; P = 0.005); however, when stone‐free was inclusive of any definition there was no difference in stone‐free rates (RR 1.10, 95% CI 0.98–1.23; P = 0.10). Subgroup analysis of SDD did not result in any significant differences. Cost savings ranged from $932.37 to a mean (standard deviation) $5327 (442) United States Dollars per case. No studies reported patient satisfaction data.
Conclusions
Ambulatory PCNL seems to be a safe and efficacious model for select patients. Selection bias likely influenced ambulatory outcomes; however, this supports overall safety of current ambulatory inclusion criteria.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.
- Division of Urology, Department of Surgery, McMaster University, Hamilton, Ontario, Canada.
- Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada.
- Department of Urology, St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada.
ORCID profiles: Katie Du
Cite
APA
Du, K., Uy, M., Cheng, A., Millan, B., Shayegan, B., & Matsumoto, E. (2025). Comparing ambulatory to inpatient percutaneous nephrolithotomy: systematic review and meta‐analysis. BJU International. https://doi.org/10.1111/bju.16601
Vancouver
Du K, Uy M, Cheng A, Millan B, Shayegan B, Matsumoto E. Comparing ambulatory to inpatient percutaneous nephrolithotomy: systematic review and meta‐analysis. BJU International. 2025. doi:10.1111/bju.16601
BibTeX
@article{Du2025,
author = {Du, Katie and Uy, Michael and Cheng, Alan and Millan, Braden and Shayegan, Bobby and Matsumoto, Edward},
title = {Comparing ambulatory to inpatient percutaneous nephrolithotomy: systematic review and meta‐analysis},
journal = {BJU International},
year = {2025},
doi = {10.1111/bju.16601}
}
EUVIMED